How much does one month of enzalutamide/enzalutamide treatment cost approximately?

Enzalutamide/enzalutamide is a new androgen receptor inhibitor widely used in the systemic treatment of prostate cancer. With the development of precision treatment concepts, enzalutamide has become an important drug choice for advanced prostate cancer, especially castration-resistant prostate cancer, and it is recommended in domestic and foreign guidelines. This drug inhibits the growth and spread of tumor cells by blocking the androgen receptor signaling pathway, and has clear value in delaying disease progression and improving quality of life.

In terms of indications, enzalutamide is mainly used for metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mHSPC). Both patients who have received chemotherapy and those in the pre-chemotherapy stage can benefit from enzalutamide treatment. Compared with traditional hormone therapy or chemotherapy alone, enzalutamide is more effective in delaying tumor progression and reducing the risk of bone metastasis complications. Due to its convenient oral administration and good long-term tolerance, more and more patients tend to choose this option.

As for the cost issue, the current common specification in the domestic market is 40mg*112 capsules, and the price per box is about more than 5,000 yuan. According to the recommended dosage, take 160 mg orally daily, which means you need to take four pills every day and consume about one box of medicine every month. Under the coverage of medical insurance policies, the actual out-of-pocket payment ratio of patients will be significantly reduced, and the financial burden will be alleviated. If reimbursed through medical insurance, the actual cost may be lower than the market retail price, which is particularly important for the patient's long-term treatment.

In addition, there are also generic drugs from India on the market. Their main ingredients and dosage are the same as the original drugs, but they have obvious advantages in price. The cost of the Indian generic version of the drug for one month is about more than 2,000 yuan, and the specific price will change with exchange rate fluctuations.

Reference materials:https://www.xtandi.com/